> News > Genknowme’s Biological Age Patent is filed
21.03
2022

Genknowme’s Biological Age Patent is filed

A big milestone has been reached! A patent application for genknowme’s Biological Age has been filed.

Genknowme has developed a new interpretation of chronological age: the most comprehensive multifactorial biological age assessment on the market, which represents a meaningful measure, highlighting the impact of lifestyle on our genes.

This patent filing is a significant step in our research and development program. It will be followed by many other contributions from Genknowme, to the thriving field of epigenetics.

We would like to thank all the people and institutions involved in this process without whom this would not have been possible: the PACTT, the CHUV, UNISANTE, Isler et Pedrazzini, the FIT, Innosuisse, the SPEI, and the Biopôle.

 

See original news

Company related to the news